Dapiprazol prevents U50,488H-mediated suppression of preparatory components of drinking behavior in rats.
In a previous study, we found that the kappa opioid agonist U50,488H (U50) suppresses both appetitive and consummatory components of drinking behavior in rats trained to negotiate water in a straight runway. U50 also activates diuresis. Kappa opioid mechanisms could therefore play a dissipative role in the body's water balance. Since naloxone inhibits diuresis, but not hypodipsia produced by U50, these effects are probably mediated also by nonopioid mechanisms. In rats trained to negotiate water in a straight runway, we have studied the influence on the hypodipsic effects of U50 of the selective alpha-1 adrenoceptor antagonist dapiprazol (DAP), which we found to inhibit U50-mediated diuresis. When given alone, DAP (3 and 6 mg/kg IP) influenced neither running for water nor water intake; neither did it prevent the suppression of water intake produced by U50 (8 mg/kg IP) across the test. However, it did antagonize the U50-mediated slowing of running for water. Alpha-1 adrenoceptors thus appear to play a role in U50's effects on diuresis and the appetitive, but not consummatory, aspects of drinking.
Nencini
P
P
Institute of Medical Pharmacology, University La Sapienza, Rome, Italy.
Graziani
M
M
Valeri
P
P
D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003864:Depression, Chemical; D004231:Diuresis / Q000187:drug effects; D004327:Drinking Behavior / Q000187:drug effects*; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D010879:Piperazines; D011759:Pyrrolidines / Q000037:antagonists & inhibitors*; D051381:Rats; D011919:Rats, Inbred Strains; D014230:Triazoles / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D010879:Piperazines; D011759:Pyrrolidines; D014230:Triazoles; D009270:Naloxone; C035289:dapiprazole; D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer